Search Results

There are 7803 results for: content related to: Managing anticoagulation for atrial fibrillation: current issues and future strategies

  1. You have free access to this content
    Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

    Journal of Internal Medicine

    Volume 278, Issue 1, July 2015, Pages: 1–18, A. M. Shields and G. Y. H. Lip

    Version of Record online : 15 APR 2015, DOI: 10.1111/joim.12360

  2. You have free access to this content
    Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives

    European Journal of Haematology

    Volume 95, Issue 5, November 2015, Pages: 389–404, Antonio Gómez-Outes, Mª Luisa Suárez-Gea, Ramón Lecumberri, Ana Isabel Terleira-Fernández and Emilio Vargas-Castrillón

    Version of Record online : 16 JUL 2015, DOI: 10.1111/ejh.12610

  3. You have free access to this content
    Advantages and limitations of the new anticoagulants

    Journal of Internal Medicine

    Volume 275, Issue 1, January 2014, Pages: 1–11, S. Schulman

    Version of Record online : 11 OCT 2013, DOI: 10.1111/joim.12138

  4. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Version of Record online : 19 NOV 2013, DOI: 10.1002/clc.22204

  5. You have full text access to this OnlineOpen article
    Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real-world” observational study in the United States

    International Journal of Clinical Practice

    Volume 70, Issue 9, September 2016, Pages: 752–763, Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Amanda Bruno and Hemant Phatak

    Version of Record online : 23 AUG 2016, DOI: 10.1111/ijcp.12863

  6. New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

    Journal of Cardiovascular Electrophysiology

    Volume 22, Issue 8, August 2011, Pages: 948–955, JUAN F. VILES-GONZALEZ, VALENTIN FUSTER and JONATHAN L. HALPERIN

    Version of Record online : 10 JUN 2011, DOI: 10.1111/j.1540-8167.2011.02104.x

  7. You have free access to this content
    Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S100–S107, John W. Eikelboom and Robert G. Hart

    Version of Record online : 3 MAR 2012, DOI: 10.1002/ajh.23136

  8. You have free access to this content
    Advances in Stroke Prevention in Atrial Fibrillation: Enhanced Risk Stratification Combined With the Newer Oral Anticoagulants

    Clinical Cardiology

    Volume 36, Issue 6, June 2013, Pages: 312–322, Freek W. A. Verheugt

    Version of Record online : 8 APR 2013, DOI: 10.1002/clc.22122

  9. You have free access to this content
    Oral Anticoagulants to Reduce the Risk of Stroke in Atrial Fibrillation: How Should a Clinician Choose?

    Clinical Cardiology

    Volume 36, Issue 11, November 2013, Pages: 663–670, Ilyas Mohammed, Wajihuddin Syed and Peter R. Kowey

    Version of Record online : 24 JUL 2013, DOI: 10.1002/clc.22173

  10. New Avenues for Anticoagulation in Atrial Fibrillation

    Clinical Pharmacology & Therapeutics

    Volume 93, Issue 1, January 2013, Pages: 68–77, S Mantha, K Cabral and J Ansell

    Version of Record online : 5 DEC 2012, DOI: 10.1038/clpt.2012.197

  11. Clinical Update on the Management of Atrial Fibrillation

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 4, April 2013, Pages: 422–446, Ilya M. Danelich, Brent N. Reed, Ian B. Hollis, Abigail M. Cook and Jo E. Rodgers

    Version of Record online : 1 APR 2013, DOI: 10.1002/phar.1217

  12. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation

    Journal of Cardiovascular Electrophysiology

    Volume 27, Issue 2, February 2016, Pages: 147–153, ANDREAS RILLIG, TINA LIN, JOAQUINA PLESMAN, CHRISTIAN-H. HEEGER, CHRISTINE LEMES, ANDREAS METZNER, SHIBU MATHEW, ERIK WISSNER, PETER WOHLMUTH, FEIFAN OUYANG, KARL-HEINZ KUCK and ROLAND RICHARD TILZ

    Version of Record online : 23 NOV 2015, DOI: 10.1111/jce.12856

  13. You have free access to this content
    Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 2, April 2014, Pages: 118–135, J. W. Cheng and G. Barillari

    Version of Record online : 3 JAN 2014, DOI: 10.1111/jcpt.12122

  14. You have free access to this content
    Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 628–636, Y. Lu, R. Branstad, R. M. Karim and R. W. Asinger

    Version of Record online : 24 SEP 2014, DOI: 10.1111/jcpt.12207

  15. You have free access to this content
    Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 10, October 2012, Pages: 1979–1987, V. PENGO, L. CRIPPA, A. FALANGA, G. FINAZZI, F. MARONGIU, M. MOIA, G. PALARETI, D. POLI, S. TESTA, E. TIRAFERRI, A. TOSETTO, A. TRIPODI, S. SIRAGUSA and C. MANOTTI

    Version of Record online : 1 OCT 2012, DOI: 10.1111/j.1538-7836.2012.04866.x

  16. You have free access to this content
    Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue 8, August 2009, Pages: 1313–1320, P. C. WONG, E. J. CRAIN, C. A. WATSON and B. XIN

    Version of Record online : 3 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03503.x

  17. You have free access to this content
    A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation

    Journal of Internal Medicine

    Volume 279, Issue 5, May 2016, Pages: 467–476, G. Y. H. Lip, T. Potpara, G. Boriani and C. Blomström-Lundqvist

    Version of Record online : 22 MAR 2016, DOI: 10.1111/joim.12468

  18. Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin

    Pacing and Clinical Electrophysiology

    Volume 38, Issue 6, June 2015, Pages: 731–737, COREY M. COLEMAN, SHADEN KHALAF, STEVEN MOULD, OUSSAMA WAZNI, MOHAMED KANJ, WALID SALIBA and DANIEL CANTILLON

    Version of Record online : 1 APR 2015, DOI: 10.1111/pace.12618

  19. Clinical pre-test of a computerised antithrombotic risk assessment tool for stroke prevention in atrial fibrillation patients: giving consideration to NOACs

    Journal of Evaluation in Clinical Practice

    Volume 22, Issue 6, December 2016, Pages: 896–902, Yishen Wang and Beata Bajorek

    Version of Record online : 7 JUN 2016, DOI: 10.1111/jep.12554

  20. You have free access to this content
    Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 707–717, Yoon K. Loke, Shiva Pradhan, Jessica Ka-yan Yeong and Chun Shing Kwok

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bcp.12376